Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anxiety | 23 | 2025 | 167 | 4.820 |
Why?
|
| Anxiety Disorders | 17 | 2023 | 69 | 4.720 |
Why?
|
| Stress Disorders, Post-Traumatic | 16 | 2023 | 62 | 4.450 |
Why?
|
| Hope | 6 | 2024 | 7 | 3.550 |
Why?
|
| Adult | 56 | 2025 | 1567 | 2.700 |
Why?
|
| Humans | 79 | 2025 | 4936 | 2.500 |
Why?
|
| Smoking Cessation | 14 | 2025 | 135 | 2.320 |
Why?
|
| Female | 53 | 2025 | 2523 | 2.230 |
Why?
|
| Male | 55 | 2025 | 2491 | 2.220 |
Why?
|
| Adaptation, Psychological | 9 | 2024 | 44 | 2.170 |
Why?
|
| Mental Health | 6 | 2024 | 57 | 1.840 |
Why?
|
| Middle Aged | 32 | 2025 | 967 | 1.760 |
Why?
|
| Optimism | 3 | 2024 | 4 | 1.670 |
Why?
|
| Stress, Psychological | 4 | 2024 | 86 | 1.650 |
Why?
|
| Resilience, Psychological | 3 | 2024 | 16 | 1.600 |
Why?
|
| Young Adult | 25 | 2024 | 787 | 1.590 |
Why?
|
| Marijuana Abuse | 3 | 2017 | 9 | 1.560 |
Why?
|
| Depression | 8 | 2024 | 125 | 1.540 |
Why?
|
| Cyclonic Storms | 3 | 2023 | 16 | 1.530 |
Why?
|
| Psychotherapy | 6 | 2025 | 11 | 1.440 |
Why?
|
| Emotions | 6 | 2022 | 75 | 1.400 |
Why?
|
| Self Efficacy | 4 | 2023 | 34 | 1.340 |
Why?
|
| Motivation | 7 | 2024 | 69 | 1.310 |
Why?
|
| Vaping | 2 | 2020 | 9 | 1.230 |
Why?
|
| Adolescent | 16 | 2025 | 758 | 1.200 |
Why?
|
| Tobacco Use Disorder | 5 | 2023 | 49 | 1.020 |
Why?
|
| Fatigue | 2 | 2024 | 9 | 1.000 |
Why?
|
| Panic Disorder | 3 | 2021 | 4 | 0.950 |
Why?
|
| Aged | 11 | 2024 | 703 | 0.950 |
Why?
|
| Electronic Nicotine Delivery Systems | 3 | 2023 | 18 | 0.950 |
Why?
|
| Self Report | 7 | 2020 | 67 | 0.890 |
Why?
|
| Treatment Outcome | 14 | 2025 | 177 | 0.870 |
Why?
|
| Cancer Survivors | 3 | 2018 | 14 | 0.820 |
Why?
|
| Veterans | 5 | 2023 | 17 | 0.810 |
Why?
|
| Mood Disorders | 2 | 2021 | 4 | 0.810 |
Why?
|
| Writing | 4 | 2023 | 9 | 0.780 |
Why?
|
| Firefighters | 5 | 2023 | 10 | 0.740 |
Why?
|
| Intimate Partner Violence | 4 | 2024 | 8 | 0.720 |
Why?
|
| Smoking | 8 | 2024 | 89 | 0.710 |
Why?
|
| Sleep | 3 | 2024 | 62 | 0.660 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 17 | 0.660 |
Why?
|
| Borderline Personality Disorder | 4 | 2025 | 48 | 0.650 |
Why?
|
| Cross-Sectional Studies | 7 | 2020 | 269 | 0.640 |
Why?
|
| Attitude to Health | 1 | 2019 | 13 | 0.610 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 96 | 0.600 |
Why?
|
| Tobacco Products | 1 | 2020 | 36 | 0.600 |
Why?
|
| Smokers | 9 | 2024 | 48 | 0.580 |
Why?
|
| Psychometrics | 7 | 2023 | 94 | 0.550 |
Why?
|
| Alcohol Drinking | 5 | 2021 | 102 | 0.550 |
Why?
|
| Safety | 1 | 2017 | 2 | 0.540 |
Why?
|
| Marijuana Use | 1 | 2017 | 10 | 0.540 |
Why?
|
| United States | 7 | 2024 | 495 | 0.520 |
Why?
|
| Longitudinal Studies | 5 | 2024 | 137 | 0.510 |
Why?
|
| Alcoholism | 3 | 2024 | 42 | 0.480 |
Why?
|
| HIV Infections | 3 | 2024 | 104 | 0.480 |
Why?
|
| Iran | 4 | 2025 | 4 | 0.470 |
Why?
|
| Prospective Studies | 6 | 2023 | 111 | 0.460 |
Why?
|
| Affect | 5 | 2024 | 29 | 0.440 |
Why?
|
| Mobile Applications | 2 | 2025 | 14 | 0.430 |
Why?
|
| Affective Symptoms | 3 | 2019 | 9 | 0.420 |
Why?
|
| Surveys and Questionnaires | 4 | 2022 | 258 | 0.380 |
Why?
|
| Implosive Therapy | 2 | 2023 | 4 | 0.380 |
Why?
|
| Chronic Pain | 2 | 2023 | 22 | 0.340 |
Why?
|
| Pilot Projects | 5 | 2025 | 98 | 0.340 |
Why?
|
| Memory, Episodic | 2 | 2022 | 36 | 0.340 |
Why?
|
| Military Personnel | 2 | 2024 | 17 | 0.330 |
Why?
|
| Neuroticism | 2 | 2021 | 5 | 0.330 |
Why?
|
| Pandemics | 2 | 2021 | 73 | 0.320 |
Why?
|
| Protective Factors | 2 | 2020 | 8 | 0.310 |
Why?
|
| Clinical Protocols | 2 | 2020 | 4 | 0.310 |
Why?
|
| Risk Factors | 3 | 2020 | 159 | 0.310 |
Why?
|
| Substance-Related Disorders | 2 | 2023 | 47 | 0.310 |
Why?
|
| Depressive Disorder | 2 | 2021 | 12 | 0.300 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2024 | 20 | 0.300 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2018 | 8 | 0.280 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2017 | 4 | 0.260 |
Why?
|
| Agoraphobia | 2 | 2017 | 2 | 0.250 |
Why?
|
| Telemedicine | 2 | 2024 | 37 | 0.250 |
Why?
|
| Comorbidity | 3 | 2021 | 47 | 0.240 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 318 | 0.240 |
Why?
|
| Qualitative Research | 1 | 2025 | 38 | 0.220 |
Why?
|
| Foster Home Care | 1 | 2024 | 6 | 0.220 |
Why?
|
| Texas | 3 | 2020 | 190 | 0.210 |
Why?
|
| Quality of Life | 3 | 2018 | 87 | 0.190 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 51 | 0.190 |
Why?
|
| Sleep Wake Disorders | 2 | 2024 | 29 | 0.190 |
Why?
|
| Students | 2 | 2023 | 120 | 0.180 |
Why?
|
| Pain | 2 | 2023 | 41 | 0.180 |
Why?
|
| Research Design | 1 | 2021 | 29 | 0.170 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 13 | 0.170 |
Why?
|
| Anhedonia | 1 | 2021 | 4 | 0.170 |
Why?
|
| Underage Drinking | 1 | 2021 | 4 | 0.170 |
Why?
|
| Cigarette Smoking | 2 | 2019 | 39 | 0.170 |
Why?
|
| Rural Population | 1 | 2021 | 10 | 0.170 |
Why?
|
| Patient Dropouts | 1 | 2021 | 4 | 0.170 |
Why?
|
| Models, Psychological | 2 | 2017 | 31 | 0.160 |
Why?
|
| Obesity | 1 | 2022 | 115 | 0.160 |
Why?
|
| Waiting Lists | 1 | 2020 | 3 | 0.160 |
Why?
|
| Risk | 1 | 2019 | 34 | 0.150 |
Why?
|
| Perception | 1 | 2019 | 32 | 0.150 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 34 | 0.150 |
Why?
|
| Survivors | 1 | 2019 | 14 | 0.150 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 83 | 0.150 |
Why?
|
| Floods | 1 | 2019 | 4 | 0.150 |
Why?
|
| Exercise | 1 | 2022 | 173 | 0.150 |
Why?
|
| Psychological Trauma | 1 | 2019 | 3 | 0.150 |
Why?
|
| Sex Offenses | 1 | 2019 | 4 | 0.150 |
Why?
|
| Crime Victims | 1 | 2019 | 9 | 0.150 |
Why?
|
| Occupational Diseases | 1 | 2018 | 4 | 0.140 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 53 | 0.140 |
Why?
|
| Ecological Momentary Assessment | 1 | 2018 | 13 | 0.140 |
Why?
|
| Phobia, Social | 1 | 2017 | 1 | 0.130 |
Why?
|
| Outpatients | 1 | 2017 | 11 | 0.130 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2017 | 5 | 0.130 |
Why?
|
| Expressed Emotion | 1 | 2017 | 2 | 0.130 |
Why?
|
| Binge Drinking | 1 | 2017 | 13 | 0.130 |
Why?
|
| Emotional Intelligence | 1 | 2017 | 15 | 0.130 |
Why?
|
| Computers | 3 | 2022 | 16 | 0.120 |
Why?
|
| Suicidal Ideation | 1 | 2017 | 20 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 3 | 2023 | 39 | 0.120 |
Why?
|
| Feedback | 3 | 2021 | 31 | 0.120 |
Why?
|
| Sexual Behavior | 2 | 2024 | 27 | 0.090 |
Why?
|
| Sexual Partners | 2 | 2024 | 24 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 262 | 0.070 |
Why?
|
| Cognition | 2 | 2018 | 140 | 0.060 |
Why?
|
| Proof of Concept Study | 1 | 2025 | 6 | 0.060 |
Why?
|
| Child, Foster | 1 | 2024 | 2 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2024 | 3 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2024 | 32 | 0.050 |
Why?
|
| Sex Factors | 1 | 2024 | 76 | 0.050 |
Why?
|
| Caregivers | 1 | 2024 | 32 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2024 | 180 | 0.050 |
Why?
|
| Latin America | 1 | 2023 | 5 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 1 | 2023 | 2 | 0.050 |
Why?
|
| Intention | 1 | 2022 | 19 | 0.050 |
Why?
|
| Nicotine | 1 | 2023 | 38 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2022 | 48 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 137 | 0.040 |
Why?
|
| Reward | 1 | 2021 | 9 | 0.040 |
Why?
|
| Aggression | 1 | 2021 | 14 | 0.040 |
Why?
|
| Psychopathology | 1 | 2021 | 11 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 115 | 0.040 |
Why?
|
| Memory Disorders | 1 | 2021 | 36 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 31 | 0.040 |
Why?
|
| Internet | 1 | 2020 | 34 | 0.040 |
Why?
|
| Universities | 1 | 2020 | 80 | 0.040 |
Why?
|
| Helping Behavior | 1 | 2019 | 1 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2021 | 341 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 73 | 0.040 |
Why?
|
| Social Support | 1 | 2019 | 28 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 23 | 0.040 |
Why?
|
| Age Factors | 1 | 2019 | 65 | 0.040 |
Why?
|
| Self-Control | 1 | 2018 | 14 | 0.040 |
Why?
|
| Individuality | 1 | 2018 | 15 | 0.040 |
Why?
|
| Urban Population | 1 | 2018 | 17 | 0.040 |
Why?
|
| Self Concept | 1 | 2018 | 18 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2018 | 17 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 24 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 17 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 5 | 0.030 |
Why?
|
| Child | 1 | 2021 | 627 | 0.030 |
Why?
|
| Agonistic Behavior | 1 | 2017 | 1 | 0.030 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2017 | 1 | 0.030 |
Why?
|
| Afghan Campaign 2001- | 1 | 2017 | 1 | 0.030 |
Why?
|
| Avoidance Learning | 1 | 2017 | 9 | 0.030 |
Why?
|
| Fear | 1 | 2017 | 7 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2017 | 14 | 0.030 |
Why?
|
| Thinking | 1 | 2017 | 9 | 0.030 |
Why?
|
| Arousal | 1 | 2017 | 6 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2017 | 21 | 0.030 |
Why?
|
| Suicide | 1 | 2017 | 10 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2017 | 46 | 0.030 |
Why?
|
| Citalopram | 1 | 2015 | 2 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 10 | 0.030 |
Why?
|
| Paroxetine | 1 | 2015 | 8 | 0.030 |
Why?
|
| Mindfulness | 1 | 2015 | 9 | 0.030 |
Why?
|